Back to Search
Start Over
A thermoresponsive hydrophobically modified hydroxypropylmethylcellulose/cyclodextrin injectable hydrogel for the sustained release of drugs.
- Source :
-
International journal of pharmaceutics [Int J Pharm] 2020 Feb 15; Vol. 575, pp. 118845. Date of Electronic Publication: 2019 Dec 10. - Publication Year :
- 2020
-
Abstract
- The objective of this study was to develop a thermoresponsive injectable hydrogel for the sustained release of drugs by taking advantage of host-guest interactions between a hydrophobically modified hydroxypropylmethyl cellulose (HM-HPMC) and cyclodextrin (CD). A thermoresponsive injectable hydrogel was prepared by simply adding CDs to HM-HPMC hydrogel. The HM-HPMC hydrogel was converted into a sol with a low viscosity through host-guest interactions with CDs. The HM-HPMC/β-CD hydrogel became a gel near body temperature where the host dissociated from the hydrophobic moieties of the polymer in response to the temperature. The yield stress of the HM-HPMC became progressively lower on the addition of β-CD which was desirable in the case of developing an injectable formulation. When the HM-HPMC/β-CD hydrogel containing indocyanine green (ICG) was subcutaneously administered to mice, the fluorescence of the ICG remained relatively constant for 24 h after the administration, which was substantially longer than that for ICG alone or an HPMC formulation. The plasma insulin level was maintained for a longer period of time when the HM-HPMC/β-CD containing insulin was administered and the MRT value was increased by 1.6 times compared to a solution of insulin alone. In addition, the HM-HPMC/β-CD hydrogel formulation showed a prolonged hypoglycemic effect in response to the insulin which was slowly released from the hydrogel. A thermoresponsive injectable hydrogel was successfully constructed from the highly viscous HM-HPMC and β-CD, and the resulting formulation functioned as a sustained release carrier for drugs.<br />Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2019 Elsevier B.V. All rights reserved.)
- Subjects :
- Animals
Delayed-Action Preparations administration & dosage
Delayed-Action Preparations chemistry
Delayed-Action Preparations pharmacokinetics
Drug Liberation
Hydrogels chemistry
Hydrogels pharmacokinetics
Hydrophobic and Hydrophilic Interactions
Hypoglycemic Agents blood
Hypoglycemic Agents chemistry
Hypoglycemic Agents pharmacokinetics
Hypromellose Derivatives chemistry
Hypromellose Derivatives pharmacokinetics
Injections
Insulin blood
Insulin chemistry
Insulin pharmacokinetics
Male
Mice
Temperature
beta-Cyclodextrins chemistry
beta-Cyclodextrins pharmacokinetics
Hydrogels administration & dosage
Hypoglycemic Agents administration & dosage
Hypromellose Derivatives administration & dosage
Insulin administration & dosage
beta-Cyclodextrins administration & dosage
Subjects
Details
- Language :
- English
- ISSN :
- 1873-3476
- Volume :
- 575
- Database :
- MEDLINE
- Journal :
- International journal of pharmaceutics
- Publication Type :
- Academic Journal
- Accession number :
- 31836484
- Full Text :
- https://doi.org/10.1016/j.ijpharm.2019.118845